The Global Fund invests more than US$5 billion a year to defeat HIV, TB and malaria and ensure a healthier, safer, more equitable future for all.

We unite the world to find solutions that have the most impact, and we take them to scale worldwide. It’s working. We won’t stop until the job is finished.

Impact

lives saved through the Global Fund partnership

Results

HIV and AIDS

people on antiretroviral therapy for HIV in 2023

HIV and AIDS

Tuberculosis

7.1

people with TB treated in 2023

Tuberculosis

Malaria

227

mosquito nets distributed in 2023

Malaria

A Decade of Progress: Halting Drug-Resistant Malaria in Southeast Asia

Digital Solutions Help Catch and Contain Outbreaks in the Democratic Republic of the Congo

Patterns of Past, Present, Promise: A Ritual of Resilience

06 June 2025

GC7 Grant Reprioritization: Updated Timelines
05 June 2025

African Religious Leaders Call for a Fully Funded Global Fund
20 May 2025

Takeda, the Longest-Standing Corporate Partner of the Global Fund, Pledges to the Eighth Replenishment
16 May 2025

Grant Adaptation Measures for Grant Cycle 7
14 May 2025

Global Fund Board Backs Prioritization of Lifesaving Interventions amid Crisis, Urges Strong Eighth Replenishment to Protect Progress
06 May 2025

In Historic First, the Global Fund Procures African-Made First-Line HIV Treatment

News Releases Updates Events

Results Report 2024

Eighth Replenishment
Investment Case

Stories Opinion Videos

Learn More

More Global Fund Sites

Data Explorer

Data Service

Digital Library